One of the consistent cardiovascular changes associated with aging is the decrease in maximal heart rate to exercise. In the past, we have explored the mechanism for this decrease by examining b-adrenoceptor change with aging. Using adipocytes as a prototype cell that has both b1- and b2- adrenoceptors, we could not identify any changes in b-adrenoceptor sensitivity with aging. We then tested the hypothesis that excessive adenosine release or sensitivity was the abnormality with aging that results in the decrease in maximal heart rate. Using theophylline to block adenosine receptors, we were unable to demonstrate that adenosine had a major role in this down-regulated response in the elderly. This present study explored the role of L-type calcium channels, and the effect of blocking them with diltiazem, in the cardiovascular response to maximal exercise with aging. The hypothesis was that if aging is associated with a down-regulated L-type calcium channel, or the inability to keep the calcium channel in an open state, then elderly subjects would have less of a heart rate effect during exercise with diltiazem administration than the young group. Thus, a group of healthy young and old men (n+8 in each) were subjected to maximal exercise test twice, once with placebo and once after diltiazem infusion. Our data were corrected to plasma concentration of diltiazm. Indeed, we found that the young group had a greater decrease in maximal heart rate to exercise than the old group (young:185 +/- with placebo, 178 +/- with diltiazem; old 150 +/- with placebo, 148 +/- with diiltiazm). When we correlated the plasma concentration of diltiazem at the end of exercise with the change in maximal heart rate (placebo- diltiazem) in the two age groups, the young group demonstrated a significant correlation (p+0.05) With increasing change in heart rat to increasing diltiazem concentration, while the old group had no such correlation. These data suggest that one explanation for the reduced maximal heart rate response with aging may very well be secondary to abnormal calcium channels in pacemaker cells resulting in slower depolarization to stimuli.

Project Start
1997-12-01
Project End
1998-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
37
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Hayden, Kathleen M; Baker, Laura D; Bray, George et al. (2018) Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study. Alzheimers Dement (Amst) 10:41-48
Shah, V N; Sippl, R; Joshee, P et al. (2018) Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance. Osteoporos Int 29:733-739
Jensen, Thomas; Bjornstad, Petter; Johnson, Richard J et al. (2018) Copeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI Study. Can J Diabetes :
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
Millstein, Richard J; Pyle, Laura L; Bergman, Bryan C et al. (2018) Sex-specific differences in insulin resistance in type 1 diabetes: The CACTI cohort. J Diabetes Complications 32:418-423
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912

Showing the most recent 10 out of 1065 publications